Beta
Back to VEEV.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
eps-chart

VEEV EPS

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for VEEV's EPS in Q4'26 shows a value of 1.49 USD, marking a continued upward trajectory from the previous quarter's 1.44 USD in Q3'26 and representing the highest point in the observed period. Over the timeframe from Q1'24 to Q4'26, VEEV's EPS has exhibited a strong overall growth trend, rising from 0.82 USD to 1.49 USD with consistent quarter-over-quarter increases, except for a minor dip in Q2'26 to 1.23 USD following a peak of 1.40 USD in Q1'26. Year-over-year EPS growth has been predominantly positive, averaging around 25-50% in most quarters, though it experienced a notable decline of -24.8% in Q4'24 before rebounding sharply to 51.4% in Q2'25; this volatility underscores resilient underlying performance amid periodic fluctuations, positioning VEEV for sustained profitability in the healthcare IT sector.